baber/WOPTO huggingface dataset:
Patent EP-1087517-A1 (EP)
Inventor: KOBAYASHI T
IPC: H02P6/00
Filed: 1999-05-19
Abstract: In order to reduce undesired sound caused by circular
ring oscillation in the diameter direction of the stator by
an electromagnetic force, electromagnetic force drift memory
13 stores a drift information of the electromagnetic force
to cause the circular ring oscillation of the stator 21, and
this electromagnetic force drift information is read out
according to the position information , and it is supplied
to a correction coefficient generating circuitry 12.
Correction coefficient generating circuitry 12 corrects the
amplitude component of the activation current wave form by
forming correction coefficient β(t) of the activation current
so as to cancel the electromagnetic force harmonic component
in a diameter direction as a main reason of the circular ring
oscillation of the stator 21.
Patent EP-1091956-A1 (EP)
Inventor: KOZLOWSKI JOSEPH A
IPC: C07D405/14
Filed: 1999-06-28
Abstract: Dérivés hétérocycliques de composés de pipérazine di-N-substituée ou de pipéridine 1,4-disubstituée représentés par la formule (I) (y compris tous les isomères, sels et solvats) dans laquelle l'un d'entre Y et Z est -N- et l'autre est  N- ou -CH-; X est -O-, -S-, -SO-, -SO2- ou -CH2-, Q est de formule (1), (2) ou (3), R est alkyle, cycloalkyle, aryle ou hétéroaryle éventuellement substitués, R<1>, R<2> et R<3> sont H ou alkyle, R<4> est alkyle, cycloalkyle ou la formule (4), R<5> est H, alkyle, -C(O)alkyle, arylcarbonyle, -SO2alkyle, aryl-sulfonyl-C(O)Oalkyle, aryloxycarbonyle, -C(O)NH-alkyle ou aryl-aminocarbonyle, la partie aryle étant éventuellement substituée, R<6> est H ou alkyle, R<7> est H, alkyle, hydroxyalkyle ou alcoxyalkyle. Lesdits dérivés sont des antagonistes de muscarine utiles pour traiter des troubles cognitifs tels que la maladie d'Alzheimer. Des compositions pharmaceutiques et des méthodes de traitement sont également décrites.
Patent EP-1121631-A1 (EP)
Inventor: LINES ANDREW M
IPC: G06F9/38
Filed: 1999-07-22
Abstract: Cette invention a trait à un processeur asynchrone (Figure 1) à processus remaniés aux fins de la mise en oeuvre d'une logique de précharge (Figure 1A).
Patent EP-1108099-A1 (EP)
Title: Dalles molletonnees pour plancher sureleve et revetements
Inventor: BERARD RAYMOND A
IPC: A47G27/04
Filed: 1999-07-29
Abstract: Des dalles (16) destinées à être utilisées avec un plancher surélevé (10) comprennent un molleton (20) épais et résilient qui est soudé directement sur toute la surface de la dalle (16) et qui la recouvre. Le molleton (20) fait office de couche arrière d'un système classique de traitement du sol du fait qu'il absorbe les chocs et qu'il atténue les sons. Un module (22) en tissu à face renforcée ne comportant qu'une couche avant (24) et une couche (26) de stabilisation est utilisé pour recouvrir le molleton (20) afin de protéger ce dernier de l'usure et de donner un aspect attractif au sol. Le module (22) en tissu à face renforcée peut être détachable ou bien fixé directement au molleton. Dans une autre forme de réalisation, des fixations à boucles et crochets peuvent être utilisées pour fixer le molleton au module de face en tissu.
Patent EP-1092095-A1 (EP)
Title: Hydraulische schaltung
Inventor: WEICKERT THOMAS
IPC: F15B11/05
Filed: 1999-05-31
Abstract: Offenbart ist eine LUDV-Schaltung zur Ansteuerung zumindest eines lastniedrigeren (6) und eines lasthöheren (4) Verbrauchers, wobei jedem Verbraucher (4, 6) eine Meßblende (14a, 14b) und eine nachgeschaltete Druckwaage (16a, 16b) zum Konstanthalten des Druckabfalls über der Meßblende zugeordnet sind. Der Druckwaage (16a) des lastniedrigeren Verbrauchers ist ein aufsteuerbarer Bypasskanal (32) zugeordnet, über den die Druckwaage dieses Verbrauchers umgehbar ist.
Patent EP-1104419-A1 (EP)
Inventor: STEINER GERD
IPC: A61K31/425
Filed: 1999-07-20
Abstract: Compounds of the formula I:in which R1, R2, R3 and R4 have the meanings stated in the description, are described.The novel compounds are suitable for controlling diseases.
Patent EP-1105251-A1 (EP)
Inventor: JUNKER ERWIN
IPC: B23B3/16
Filed: 1999-08-09
Abstract: Die vorliegende Erfindung stellt eine Schleifmaschine mit zumindest Schleifmaschinenbett, Zustellschlitten und Schleiftisch mit Tischaufbauten zur Verfügung, die eine Drehwerkzeug-Werkzeugaufnahme (6) zum Hartdrehen vorgesehen hat. Auch wird ein Verfahren zur Bearbeitung eines Werkstückes (1) in einer Schleifmaschine vorgeschlagen, bei welchem am Werkstück (1) in der Schleifmaschine eine Hartdrehbearbeitung durchgeführt wird.
Patent EP-1112285-A1 (EP)
Inventor: JACOBS KENNETH
IPC: A61P1/02
Filed: 1999-08-10
Abstract: L'invention concerne de nouvelles protéines humaines connexes à la chordine et les polynucléotides les codant.
Patent EP-1146945-A1 (EP)
Inventor: PULEK JOHN L
IPC: B01D25/00
Filed: 1999-08-11
Abstract: L'invention concerne une cellule (20) de filtrage de fluide, laquelle comprend un séparateur (26) placé entre deux éléments filtrants (22, 24) dont les périphéries extérieures sont assujetties par un joint d'étanchéité (30). Les éléments filtrants sont formés dans un matériau qui augmente de dimension par suite de l'absorption de fluide. Le joint d'étanchéité (30) est formé dans un matériau thermoplastique dont le module d'élasticité est suffisant pour permettre une expansion radiale du joint lorsque les éléments filtrants de la cellule augmentent de dimension.
Patent EP-1121174-A1 (EP)
Inventor: KILLION DOUGLAS P
IPC: A61F2/06
Filed: 1999-09-24
Abstract: L'invention concerne un cathéter à perfusion, qui permet la perfusion d'un liquide organique et la pose simultanée d'un dispositif de traitement en un point du corps déterminé. Le cathéter à perfusion selon l'invention convient particulièrement pour la pose d'un stent. Le stent est installé à partir d'une chambre présentant des ouvertures de perfusion aux extrémités proximale et distale. Ces ouvertures sont conçues et disposées de façon qu'un liquide organique, tel que du sang, puisse passer à travers la chambre.
Patent EP-1116030-A1 (EP)
Inventor: BUECHLER JOE
IPC: G01N33/569
Filed: 1999-09-20
Abstract: L'invention concerne des procédés, des réactifs et des kits utiles pour diagnostiquer une infection par le parasite lamblia. Pour les procédés de diagnostic considérés, on a découvert des agents de liaison - englobant les anticorps polyclonaux de recombinaison - qui se lient à l'antigène α-1-giardine du parasite lamblia.
Patent EP-1148935-A1 (EP)
Inventor: ANDERSON THEODORE P
IPC: B01F11/00
Filed: 1999-12-02
Abstract: L'invention concerne un procédé permettant de produire une pâte de calfeutrage adhésive et colorée. A cet effet, (a) on introduit dans un récipient refermable une composition permettant de former la pâte de calfeutrage, laquelle composition peut être épaissie par contact avec une composition pigmentée; (b) on ajoute dans le récipient une composition pigmentée ayant une couleur prédéterminée; enfin, (c) on agite le récipient, de manière à épaissir la composition permettant de former la pâte de calfeutrage et à obtenir ainsi une pâte de calfeutrage adhésive et colorée.
Patent EP-1142394-A1 (EP)
Title: Method for tolerating defective data in a communications system
Inventor: FROEHLICH HANS-HERMANN
IPC: G07F7/10
Filed: 1999-12-20
Abstract: The invention relates to a method for tolerating defective data in a communications system with at least one transmitter and at least one receiver which communicate with each other. The invention is characterised in that when a write error or a read error occurs with the temporary data that are stored in a non-volatile memory of a data support, initial values or pre-set values are used for the transmitter or the receiver instead of an error message or the defective temporary data. This enables the communication between the transmitter and the receiver to be continued.
Patent EP-1117651-A1 (EP)
Inventor: MITTENDORF JOACHIM
IPC: C07D235/20
Filed: 1999-09-29
Abstract: L'invention porte sur des composés bis-benzimidazole de la formule générale (I) dans laquelle R?1, R2, R3 et R4¿ sont un hydrogène, un hydroxy ou un halogène, R5 et R8 sont un hydrogène, ou (C¿1?-C4)-alkyl, R?6 et R7¿ sont un hydrogène, ou (C¿1?-C6)-alkyl, hydroxy, halogène, ou (C1-C6)-alcoxy, R?9, R10 et R11¿ sont un hydrogène, halogène, nitro, cyano ou trifluorométhyle, et A est un N-hétérocycle non aromatique de 5 à 7 éléments, etc. L'invention porte également sur un procédé de préparation et d'utilisation de ces composés dans le traitement de pathologies associées à l'activité tryptasique telles que les maladies allergiques, inflammatoires et immunologiques, notamment l'asthme, la rhinite allergique, la conjonctivite allergique et la dermatite allergique.
Patent EP-1137713-A1 (EP)
Inventor: HAYASHI RYUICHI
IPC: C08L77/06
Filed: 1999-10-22
Abstract: A polyamide composition for molded products having thin-wall parts and for connectors for use in automobiles, containing: A) 100 wt parts of a semi-aromatic polyamide having a melting point of 280 to 320  DEG C and a glass transition temperature of 95 to 115  DEG C, wherein the amount of aromatic monomer constituting the polyamide is at least 30 mol %, and B) 1 to 70 wt parts of an impact resistance agent composed mainly of a modified polyolefin that has been graft-modified by means of a carboxylic acid or a carboxylic anhydride.
Patent EP-1131703-A1 (EP)
Inventor: HOLMBERG PER ANDERS
IPC: G06F9/50
Filed: 1999-11-12
Abstract: Selon l'invention, des processeurs multiples (11) à mémoire partagée sont introduits au niveau le plus haut ou à des niveaux les plus hauts de données d'un système de traitement hiérarchique réparti (1) et l'utilisation des processeurs est optimisée sur la base de flux d'événements simultanés identifiés dans le système. Selon un premier aspect, des catégories dites non en transit (NCC) d'événements sont projetées sur les processeurs multiples (11) pour procéder à une exécution simultanée. Selon un second aspect de l'invention, les processeurs (11) sont exploités sous la forme d'un pipeline multiprocesseur, dans lequel chaque événement arrivant dans le pipeline est traité par tranches à la manière d'une chaîne d'événements intérieurs, lesquelles sont exécutées à différents étages du pipeline. On obtient une structure de traitement général par ce que l'on appelle traitement matriciel, dans laquelle des catégories non en transit sont exécutées par différents ensembles de processeurs, et au moins un ensemble de processeurs fonctionne à la manière d'une pipeline multiprocesseur dans lequel un événement extérieur est traité par tranches dans différents étages de processeurs du pipeline.
Patent EP-1050274-A1 (EP)
Inventor: SUZUKI SHIGEKI
IPC: A61M37/00
Filed: 1999-10-12
Abstract: It is a purpose to provide the hemostatic material
insertion device for simplifying hemostasis of the puncture wound
in the blood vessel, and the method. More concretely, the device
comprises the following.
   (a) A cartridge, charged with hemostatic material, which is
injected into the puncture foramen   (b) A hollow sheath which holds said cartridge,   (c) An ejecting piston portion which forms a one unit with
said sheath at the rear end of the sheath and is used for
pushing out the hemostatic material charged in said
cartridge,   (d) A guide knob to slide the said cartridge inside the hollow
sheath   (e) A stopping device affixed to the front end of said hollow
sheath  
Moreover, in this hemostatic material insertion device and the
method using the device, the said cartridge, inserted into the
puncture foramen through the guide sheath, is slid backwards in
the sheath by the guide knob. As a result, it is drawn back out
of the puncture foramen, and simultaneously, the puncture foramen
is filled with a hemostatic agent charged in the cartridge by
means of the ejecting piston in the cartridge, which is united
with the said sheath.
Patent EP-1131478-A1 (EP)
Inventor: GREIF STEFFEN
IPC: D02J3/16
Filed: 1999-11-10
Abstract: A singeing machine (100) comprising a singeing burner (10) for strands of yarn (3), whereby a cooling path (15) is connected to said burner (10) and the strands of yarn (3) run in a slanted downward position therein. Said cooling path is of a sufficient length to enable the singed particles that are displaced along with the yarn to lose their adhesiveness at the end of the cooling path (15).
Patent FI-20216034-A1 (FI)
Title: Apparatus comprising electric motor
Inventor: BÄCK SIMON
IPC: H02K9/04
Filed: 2021-10-06
Abstract: There is provided an apparatus comprising an electric motor (100) having a rotor and a stator and a fan (207), wherein the rotor comprises an outer shell (102) arranged annular to the stator and said outer shell (102) is connected to a rotor shaft (104); wherein the fan (207) is arranged co-centrically to the rotor shaft (104) and rotatable with respect to the rotor shaft (104); comprising a drive system for the fan (207), means for driving the drive system by a rotation of the outer shell and means for driving the fan (207) by the drive system; and the drive system is configured to transform the rotation of the outer shell (102) to a rotation of the fan (207) with a drive ratio of 1:F, where F is higher than 1.
Patent HK-1030598-A1 (HK)
Title: Method for preparing 3-cyano-2, 4-dihalogen-5-fluor-benzoic acid
Inventor: HALLENBACH WERNER
IPC: C07C253/30
Filed: 2001-03-02
Abstract: The present invention relates to a process for preparing 3-cyano-2,4-dihalogeno-5-fluoro-benzoic acid, to intermediates for carrying out the process and to processes for preparing these intermediates.
Patent HK-1031307-A1 (HK)
Title: Improved mechanism for rotating case.
Inventor: DEMELLIER SSTEPHANE
IPC: A45D40/00
Filed: 2001-03-26
Abstract: Turning case mechanism particularly for cosmetic products, composed of a pivoting body mounted in rotation on a main piece, formed by a traveler, base and hinge elements connecting the base to the traveler, between a lower articulation point with the base and an upper articulation point with the traveler; said traveler intended to be mobile between an open or upper position and a closed or lower position, characterized in that when the traveler is in the lower position, the hinge elements are arranged at least in part below the horizontal plane that contains the lower articulation point.
Patent HK-1035742-A1 (HK)
Title: Control of gene expression
Inventor: GRAHAM MICHAEL WAYNE
IPC: C12N1/19
Filed: 2001-08-21
Abstract: The present invention relates generally to a method of modifying gene expression and to synthetic genes for modifying endogenous gene expression in a cell, tissue or organ of a transgenic organism, in particular a transgenic animal or plant. More particularly, the present invention utilises recombinant DNA technology to post-transcriptionally modify or modulate the expression of a target gene in a cell, tissue, organ or whole organism, thereby producing novel phenotypes. Novel synthetic genes and genetic constructs which are capable of repressing delaying or otherwise reducing the expression of an endogenous gene or a target gene in an organism when introduced thereto are also provided.
Patent HK-1064043-A1 (HK)
Title: Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia
Inventor: HERMIDA OCHOA ELIAS HUMBERTO
IPC: A61K31/715
Filed: 2004-09-08
Abstract: This invention is related to the use of a composition formed by sodium hyaluronate, sodium chondroitin sulfate and botulinum toxin type A for the treatment of dermal lines, and to the use of such composition in the manufacture of a product for such treatment.
Patent HK-1090674-A1 (HK)
Title: Non-fibrous polymer solution of para-aramid with high relative viscosity
Inventor: HENDRIKS ANTON JOHANNES JOSEF
IPC: D01F6/60
Filed: 2006-10-17
Abstract: The invention relates to a non-fibrous polymer solution essentially consisting of 1 to 8 wt. % para-aramid, at least 50 mole % of the aromatic moieties thereof being unsubstituted, in a mixture of a) a polar amide solvent selected from N-methyl-2-pyrrolidone, N,N′-dimethylformamide, N,N′-dimethylacetamide, tetramethylurea, and mixtures thereof; b) between 0.7 mole of an alkali or earth alkali chloride per mole amide groups of the para-aramid and 7.5 wt. % of the alkali or earth alkali chloride, and c) water; and wherein at least 50 wt. % of the formed hydrochloric acid has been neutralized to obtain a solution having a dynamic viscosity which is at least a factor three smaller than the dynamic viscosity of the polymer solution without neutralization. The invention further pertains to a process making the same and para-aramid pulp-like fiber, paper and film made from said polymer solution.
Patent HK-1090805-A1 (HK)
Title: Antimicrobial compositions
Inventor: OHNISHI TOSHIMASA
IPC: A01N31/14
Filed: 2004-11-03
Abstract: This invention concerns antimicrobial compositions that are useful for industrial applications. More specifically, it concerns antimicrobial compositions that, by combining 3-benzo[b]thiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide and one or more of 1-[[(3-iodo-2-propynyl)oxy]methoxy]-4-methoxy benzene, 1-chloro-4-[[(3-iodo-2-propynyl)oxy]methoxy] benzene, Zinc 2-pyridine thiol-1-oxide, Copper 2-pyridine thiol-1-oxide, 2-pyridine thiol-1-oxide sodium salt, 2,2-dithio-bis(pyridine-1-oxide), 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, 3-iodo-2-propynyl butylcarbamate (IPBC), 2-(n-octyl)-3(2H)-isothiazolone (OIT), 4,5-dichloro-2-(n-octyl)-3(2H)-isothiazolone (DCOIT), 2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile (chlorothalonil), 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-phenyl-methanesulfenamide (dichlofluanid), or 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-(4-methylphenyl)-methanesulfenamide (tolylfluanid) have the synergistic effect of these compounds.
Patent HK-1090815-A1 (HK)
Title: Footwear sole structure incorporating a cushioningcomponent
Inventor: JOHN SWIGART
IPC: A43B13/20
Filed: 2006-11-17
Abstract: A cushioning component for an article of footwear is disclosed that includes a fluid-filled chamber and a covering element extending over a portion of the chamber. The chamber is devoid of internal connections, and the fluid within the chamber may be at a pressure that is substantially equal to an ambient pressure. The chamber defines a plurality of lobes, and the cushioning element includes a plurality of inserts that extend between the lobes. The inserts are elongate structures that decrease the compressibility of peripheral portions of the cushioning component.
Patent HK-1104836-A1 (HK)
Title: Recombinant alpha-l-iduronidase and methods for treating diseases caused by deficiencies thereof
Inventor: HENSTRAND JOHN M
IPC: A61K9/08
Filed: 2007-11-30
Abstract: The present invention provides a recombinant human ±-L-iduronidase and biologically active fragments and mutants thereof, large scale methods to produce and purify commercial grade recombinant human, ±-L-iduronidase enzyme as well as methods to treat certain genetic disorders including ±-L-iduronidase deficiency and mucopolysaccharidosis I (MPS 1).
Patent HK-1109638-A1 (HK)
Title: Dr5 antibodies and uses thereof dr5
Inventor: ADAMS CAMELLIA W
IPC: A61K/
Filed: 2008-04-10
Abstract: The invention concerns anti-DR5 antibodies with improved properties, compositions comprising such antibodies, methods and means for making such antibodies, and their therapeutic use, in particular in the treatment of cancer.
Patent HK-1116836-A1 (HK)
Title: Multicomponent nucleic acid enzymes and methods for their use
Inventor: MOKANY ELISA
IPC: C12Q/
Filed: 2008-10-09
Abstract: The present invention relates to Multicomponent Nucleic Acid Enzymes (MNAzymes) and methods for their use. MNAzymes comprise two or more oligonucleotide components which self-assemble in the presence of one or more MNAzyme assembly facilitator molecules to form a catalytically active structure. Compositions for making MNAzymes, and collections of MNAzymes are provided. Also provided are methods for using MNAzymes for the detection, identification and/or quantification of one or more targets. The methods can be practiced in solution-based assays or in assays where one or more reaction components are attached to a support structure. The methods allow for multiplexing the MNAzyme detection to detect multiple targets in a single reaction. Also provided are kits for making the compositions, and for practicing the methods provided herein.
Patent HK-1003804-A1 (HK)
Title: Animated data display interleaving
Inventor: SCHWENDEMAN ROBERT J
IPC: H04M1/72427
Filed: 1998-04-04
Abstract: A portable communications receiver is disclosed having a receiver for receiving and detecting periodically transmitted selective call paging signals and data signals. In response to the selective call paging signal, a decoder generates control signals which allow storage of the data signals in a memory, and the display of the latest stored signals. A graphic characterization is provided for depicting the moving object. The effect of movement of the object is generated as the data signals are periodically updated and displayed. By individually animating the graphic characterization between updates, the effect of movement is enhanced. The data signals are periodically updated and include an absolute position signal for depicting an absolute position of the moving object. The data signals further include a relative position signal for depicting a relative position of the moving object relative to another moving object.
Patent HK-1006184-A1 (HK)
Title: Amalgam for filling cavities and method of preparation of compositions for the amalgam
Inventor: SUBRAMANIAM S RADHAKRISHNAN
IPC: A61K6/847
Filed: 1998-06-15
Abstract: PCT No. PCT/GB92/02101 Sec. 371 Date Nov. 21, 1994 Sec. 102(e) Date Nov. 21, 1994 PCT Filed Nov. 13, 1992 PCT Pub. No. WO92/16860 PCT Pub. Date Oct. 1, 1992.The invention relates to a method of preparing a dental amalgam that is devoid of harmful free mercury, to be used as a filler for dental cavities. In particular the invention relates to processes by which two separate compositions characterized as treated silver and silver-mercury compound are formed, which are then used in a mixture with mercury to form the dental amalgam.
Patent HK-1006154-A1 (HK)
Title: Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
Inventor: ROSINI SERGIO
IPC: A61K31/66
Filed: 1998-06-16
Abstract: This invention relates to pharmaceutic compositions for the treatment of the arthrosis by intraarticular administration of the compositions diluted in a suitable aqueous or lyophilized carrier, comprising an efficient quantity of certain diphosphonates, as will be specified later, characterized in having amino acids added thereto as stabilizers, and to a therapeutic method for the treatment of the arthrosis by intraarticular administration of said compositions into the body of human beings and animals.
Patent HK-1008118-A1 (HK)
Title: Electrochemical cell
Inventor: LUNDSGAARD JORGEN S
IPC: H01M6/10
Filed: 1998-06-24
Abstract: An electrochemical cell is described comprising a relatively thin strip of anode material, first and second electrolyte layers coated on the opposing surfaces of the anode strip, and first and second relatively thin strips of cathode material contacting the first and second electrolyte layers, thereby forming a laminate strip with the electrolyte layers and anode strip and a single cathode current conductor strip. The laminate strip is deformed such that both of the first and second strips of cathode material contact the single cathode current conductor strip along substantially the entire length thereof. In one embodiment, the cell takes the form of a spiral, in which the conductor strip is superposed to the laminate strip and the combination is rolled lengthwise, and in another embodiment, the cell takes the form of a stack in which the laminate strip is fan-folded and the conductor strip is fan-folded and inserted between the folds of the laminate strip such that the corners of the folds of the laminate strip are perpendicular to the corners of the folds of the conductor strip.